ENTRY       C06810                      Compound
NAME        Acyclovir;
            Aciclovir
FORMULA     C8H11N5O3
EXACT_MASS  225.0862
MOL_WEIGHT  225.2046
REMARK      Same as: D00222
PATHWAY     map04976  Bile secretion
BRITE       Carcinogens [BR:br08008]
             Group 3: Not classifiable as to its carcinogenicity to humans
              Compounds
               C06810  Acyclovir
            Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             D DERMATOLOGICALS
              D06 ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE
               D06B CHEMOTHERAPEUTICS FOR TOPICAL USE
                D06BB Antivirals
                 D06BB03 Aciclovir
                  D00222  Aciclovir (JP16/INN); Acyclovir (USP)
             J ANTIINFECTIVES FOR SYSTEMIC USE
              J05 ANTIVIRALS FOR SYSTEMIC USE
               J05A DIRECT ACTING ANTIVIRALS
                J05AB Nucleosides and nucleotides excl. reverse transcriptase inhibitors
                 J05AB01 Aciclovir
                  D00222  Aciclovir (JP16/INN); Acyclovir (USP)
             S SENSORY ORGANS
              S01 OPHTHALMOLOGICALS
               S01A ANTIINFECTIVES
                S01AD Antivirals
                 S01AD03 Aciclovir
                  D00222  Aciclovir (JP16/INN); Acyclovir (USP)
            USP drug classification [BR:br08302]
             Antivirals
              Antiherpetic Agents
               Acyclovir
                D00222  Aciclovir (JP16/INN); Acyclovir (USP)
            Therapeutic category of drugs in Japan [BR:br08301]
             1  Agents affecting nervous system and sensory organs
              13  Agents affecting sensory organs
               131  Ophthalmic agents
                1319  Others
                 D00222  Aciclovir (JP16/INN); Acyclovir (USP); Aciclovir granules (JP16); Aciclovir ophthalmic oinment (JP16); Aciclovir tablets (JP16)
             6  Agents against pathologic organisms and parasites
              62  Chemotherapeutics
               625  Antivirals
                6250  Antivirals
                 D00222  Aciclovir (JP16/INN); Acyclovir (USP); Aciclovir granules (JP16); Aciclovir ophthalmic oinment (JP16); Aciclovir tablets (JP16)
            Classification of Japanese OTC drugs [BR:br08313]
             Agents for integumentary system
              -- Agent for herpes labialis
               D00222  Aciclovir (JP16/INN); Acyclovir (USP)
            Risk category of Japanese OTC drugs [BR:br08312]
             Category 1
              Inorganic and organic chemicals
               Aciclovir
                D00222  Aciclovir (JP16/INN); Acyclovir (USP)
            Antiinfectives [BR:br08307]
             Antivirals
              Anti-HSV agent
               DNA polymerase inhibitor
                Purine analogue
                 Aciclovir
                  D00222  Aciclovir (JP16/INN); Acyclovir (USP)
            Cytochrome P450 interactions [BR:br08309]
             Inhbitors
              CYP1A2
               Aciclovir
                D00222  Aciclovir (JP16/INN); Acyclovir (USP)
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00222  Aciclovir
              D00222  Aciclovir granules
              D00222  Aciclovir ophthalmic oinment
              D00222  Aciclovir tablets
              D00222  Aciclovir syrup
              D00222  Aciclovir injection
              D00222  Aciclovir ointment
              D00222  Aciclovir for syrup
              D00222  Aciclovir for injection
DBLINKS     CAS: 59277-89-3
            PubChem: 9029
            ChEBI: 2453
            PDB-CCD: AC2
            NIKKAJI: J11.247J
ATOM        16
            1   N4y N    23.8700  -17.9200
            2   C8y C    25.1300  -17.4300
            3   C8y C    25.1300  -16.0300
            4   N5x N    23.8000  -15.6800
            5   C8x C    23.0300  -16.8000
            6   N5x N    26.3900  -18.1300
            7   C8y C    27.5800  -17.4300
            8   N4x N    27.5800  -16.0300
            9   C8y C    26.3200  -15.3300
            10  O5x O    26.3200  -13.9300
            11  N1a N    28.8400  -18.0600
            12  C1b C    23.8700  -19.3200
            13  O2a O    22.6100  -20.0200
            14  C1b C    21.4200  -19.3200
            15  C1b C    20.1600  -20.0200
            16  O1a O    18.9700  -19.3200
BOND        17
            1     1   2 1
            2     2   3 2
            3     3   4 1
            4     4   5 2
            5     1   5 1
            6     2   6 1
            7     6   7 2
            8     7   8 1
            9     8   9 1
            10    3   9 1
            11    9  10 2
            12    7  11 1
            13    1  12 1
            14   12  13 1
            15   13  14 1
            16   14  15 1
            17   15  16 1
///
